Drugs News and Research

RSS

Nebraska laws to protect patients and healthcare providers against unfair prescription insurance practices

Dozens of patients and state and national advocacy and healthcare groups, including Nebraska Medical Association and Nebraska Nurses Association, today urged passage of two precedent-setting consumer protection healthcare bills during a hearing at the Nebraska State Capitol. These laws would be the first in the nation to protect patients and healthcare providers against unfair prescription insurance practices.

17 Feb 2010

AHF to protest Merck’s Isentress pricing and policies at CROI

AIDS Healthcare Foundation (AHF) will host a protest Wednesday morning, February 17 at 8:00am targeting Merck and Co. Pharmaceuticals over the pricing and policies for its key HIV/AIDS drug, Isentress, the most expensive first-line AIDS treatment in the US, during the 17th Conference of Retroviruses and Opportunistic Infections (CROI) in San Francisco.

17 Feb 2010

New book by 12 world-leading scientists calls for renewed approach to drug policy

Drug policy - or really, the way our society controls and provides interventions for both legal and illegal psychoactive substances - is one of those things that seems inherently controversial.

17 Feb 2010

Belatacept costimulation blocker can prevent rejection of new organs by the immune system

Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).

17 Feb 2010

Research suggests scorpion venom could be an alternative to morphine painkiller

Scorpion venom is notoriously poisonous ― but it might be used as an alternative to dangerous and addictive painkillers like morphine, a Tel Aviv University researcher claims.

17 Feb 2010

Scotland's $13 billion chemicals sector to showcase new initiatives at Informex

Scotland's $13 billion chemicals sector will showcase innovative new initiatives at Informex this week, highlighting the country's research and manufacturing expertise, and offering integrated, world-class solutions to the global chemicals industry.

17 Feb 2010

Protein crucial in mediating anti-inflammatory actions of nuclear lipid receptors discovered

Researchers at the Swedish medical university Karolinska Institutet have discovered a protein that is crucial in mediating the anti-inflammatory actions of nuclear lipid receptors. The findings, published in the research journal Genes & Development, link lipid metabolism and inflammation and open up new possibilities for developing treatments of metabolic diseases associated with inflammation, such as diabetes and atherosclerosis.

17 Feb 2010

Orexo AB reports year-end 2009 financial results

Sales of Abstral continue to show robust growth, with royalty revenues rising sharply during the fourth quarter – up threefold from the preceding quarter. Our partner, ProStrakan, launched during 2009 Abstral in UK, Germany, France, Spain and Greece, and product launches in additional markets are imminent. Sales growth confirms that there is a substantial medical requirement in the case of cancer patients suffering from breakthrough pain.

17 Feb 2010

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Obecure Ltd (http://www.obecure.com)., a subsidiary of Bio-Light Israeli Life Science Investments Ltd., announced today the execution of a licensing and clinical supply agreement with Farmaceutici Formenti SPA, the Italian Subsidiary of the Grunenthal Group.

17 Feb 2010

Study: Researchers use genomics to decode blueprint of Plasmodium falciparum

Scientists battling malaria have earned a major victory. According to a Nature Genetics study, an international group of researchers has used genomics to decode the blueprint of Plasmodium falciparum - a strain of malaria most resistant to drugs that causes the most deaths around the world.

17 Feb 2010

FDA approves risk management program on ESA's for treating anemia due to chemotherapy

The U.S. Food and Drug Administration today approved a risk management program to inform healthcare providers and their patients about the risks of a class of drugs called Erythropoiesis-Stimulating Agents (ESAs). For patients with cancer, the program is also designed to help ensure the appropriate administration of these drugs, which they receive to treat anemia that can occur as a result of chemotherapy.

17 Feb 2010

Idaho Health Freedom Act: Unproven, untried and vague, says AARP and urges Senate committee to reject bill

As Idaho families, businesses and retirees struggle with soaring health care costs, a vague bill aimed at tackling an issue in a non-existent federal health care law could make the crisis worse for many of the state's residents. The Idaho Health Freedom Act (HB 391) is set to be heard by Idaho Senate State Affairs Committee tomorrow morning, and AARP says the legislation is unproven, untried and vague and is urging them to reject the bill.

17 Feb 2010

Iowa State University researchers awarded 30 ARRA grants worth $16.38M

Iowa State University researchers have so far won 30 grants worth a total $16.38 million from federal agencies awarding money from the American Recovery and Reinvestment Act (ARRA).

17 Feb 2010

WebMD Health introduces new enhancements for Medscape Mobile for physicians

WebMD Health Corp., the leading source of health information, today announced a set of new enhancements for Medscape Mobile to assist physicians in diagnosis and treatment at the point-of-care. Medscape Mobile, WebMD's free medical application for physicians, now provides access to thousands of in-depth clinical reference articles on diseases, conditions, and procedures, in addition to complete reference information on over 7,000 brand name, generic and OTC medications.

17 Feb 2010

ACHF receives $2.5M as gift from KCCFA in support of childhood cancer research

The Alberta Children's Hospital Foundation received a gift of $2.5 million today from the Kids Cancer Care Foundation of Alberta in support of childhood cancer research at the Alberta Children's Hospital, as well as the Alberta Children's Hospital Research Institute for Child and Maternal Health and the Southern Alberta Cancer Research Institute - both at the University of Calgary.

17 Feb 2010

High-fat ketogenic diet safe and effective for controlling childhood seizures

Current and former patients treated with the high-fat ketogenic diet to control multiple, daily and severe seizures can be reassured by the news that not only is the diet effective, but it also appears to have no long-lasting side effects, say scientists at Johns Hopkins Children's Center.

17 Feb 2010

States struggle with insurance cost and coverage in Ohio, Rhode Island and Nebraska

The Columbus Dispatch reports that a health-insurance co-operative founded by Tom Rose, a retired businessman from Marietta, Ohio, "hopes to give people who feel alone in the health-care market that power-in-numbers feeling. ... Benefits Unlimited Inc. started in 2007 and started accepting dues-paying members across the nation last month. ... Annual dues range from $25 for an individual or household to $1,500 for employers or associations with 500 or more people.

17 Feb 2010

Rhubarb may have anti-cancer properties, but more research needed

Rhubarb contains natural chemicals called polyphenols that have been shown to kill cancer cells in the lab, or prevent their growth. Baking appears to greatly increase the levels of these chemicals, UK scientists have found, but Cancer Research UK cautioned against reading too much into these results.

17 Feb 2010

Researchers adopt new technique to inhibit cancer growth

One of the difficulties of fighting cancer is that drugs often hit other non-cancerous cells, causing patients to get sick. But what if researchers could sneak cancer-fighting particles into just the cancer cells?

17 Feb 2010

NanoViricides signs research and development agreement with Dr. Eva Harris’s laboratory at UC Berkeley

NanoViricides, Inc. (the "Company"), reports that it has signed a research and development agreement with Dr. Eva Harris’s laboratory at the University of California, Berkeley (UC Berkeley).

17 Feb 2010

Drugs News and Research

Nebraska laws to protect patients and healthcare providers against unfair prescription insurance practices

AHF to protest Merck’s Isentress pricing and policies at CROI

New book by 12 world-leading scientists calls for renewed approach to drug policy

Belatacept costimulation blocker can prevent rejection of new organs by the immune system

Research suggests scorpion venom could be an alternative to morphine painkiller

Scotland's $13 billion chemicals sector to showcase new initiatives at Informex

Protein crucial in mediating anti-inflammatory actions of nuclear lipid receptors discovered

Orexo AB reports year-end 2009 financial results

Obecure enters into licensing and clinical supply agreement with Grunenthal's subsidiary for XR betahistine

Study: Researchers use genomics to decode blueprint of Plasmodium falciparum

FDA approves risk management program on ESA's for treating anemia due to chemotherapy

Idaho Health Freedom Act: Unproven, untried and vague, says AARP and urges Senate committee to reject bill

Iowa State University researchers awarded 30 ARRA grants worth $16.38M

WebMD Health introduces new enhancements for Medscape Mobile for physicians

ACHF receives $2.5M as gift from KCCFA in support of childhood cancer research

High-fat ketogenic diet safe and effective for controlling childhood seizures

States struggle with insurance cost and coverage in Ohio, Rhode Island and Nebraska

Rhubarb may have anti-cancer properties, but more research needed

Researchers adopt new technique to inhibit cancer growth

NanoViricides signs research and development agreement with Dr. Eva Harris’s laboratory at UC Berkeley

Drug Discovery - Second Edition eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News